![Alex Zhavoronkov, PhD](https://drtalks.com/wp-content/uploads/2023/01/Alex-Zhavoronkov-300x300.jpg)
Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leading clinical-stage biotechnology company developing next-generation artificial intelligence and robotics platforms for drug discovery. He is also the founder and of Deep Longevity, Inc, a spin-off of Insilico Medicine developing a broad range of artificial intelligence-based biomarkers...